Erika Hamilton Selected Research

Tyrosine (L-Tyrosine)

6/2012	Polyclonal HER2-specific antibodies induced by vaccination mediate receptor internalization and degradation in tumor cells.
9/2011	Phase II trial of dasatinib in patients with metastatic breast cancer using real-time pharmacodynamic tissue biomarkers of Src inhibition to escalate dosing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Erika Hamilton Research Topics

Disease

40	Neoplasms (Cancer) 01/2024 - 09/2011
39	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2011
7	Brain Neoplasms (Brain Tumor) 01/2021 - 01/2011
5	Disease Progression 01/2024 - 01/2018
5	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 10/2019
5	Triple Negative Breast Neoplasms 12/2022 - 01/2014
3	Thrombocytopenia (Thrombopenia) 01/2022 - 01/2018
3	Fatigue 01/2022 - 01/2018
3	Vomiting 01/2022 - 01/2018
3	Diarrhea 01/2021 - 01/2018
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2023 - 10/2017
2	Uterine Neoplasms (Uterine Cancer) 05/2023 - 01/2019
2	Ovarian Epithelial Carcinoma 01/2023 - 01/2020
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2023 - 01/2022
2	Pneumonia (Pneumonitis) 01/2023 - 01/2022
2	Neoplasm Metastasis (Metastasis) 09/2022 - 01/2014
2	Circulating Neoplastic Cells 01/2022 - 12/2018
2	Nausea 01/2020 - 01/2018
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 09/2023
1	Arthralgia (Joint Pain) 07/2023
1	Hot Flashes 07/2023
1	Carcinogenesis 06/2023
1	Hematologic Neoplasms (Hematological Malignancy) 05/2023
1	Endometrial Neoplasms (Endometrial Cancer) 01/2023
1	Asthenia 01/2023
1	Dehydration (Water Stress) 01/2022
1	Anemia 01/2022

Drug/Important Bio-Agent (IBA)

12	Hormones (Hormone)IBA 06/2023 - 04/2016
10	Trastuzumab (Herceptin)FDA Link 09/2023 - 02/2012
9	human ERBB2 proteinIBA 05/2023 - 01/2018
9	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2011
7	Immunoconjugates (Immunoconjugate)IBA 01/2024 - 10/2019
7	Estrogen ReceptorsIBA 07/2023 - 10/2011
6	Ado-Trastuzumab EmtansineIBA 01/2024 - 01/2018
6	tucatinibIBA 09/2023 - 01/2018
5	niraparibIBA 01/2024 - 01/2022
5	ErbB Receptors (EGF Receptor)IBA 09/2023 - 01/2021
4	trastuzumab deruxtecanIBA 01/2024 - 01/2022
4	Fulvestrant (Faslodex)FDA Link 07/2023 - 01/2020
4	Monoclonal AntibodiesIBA 01/2023 - 02/2012
4	PlatinumIBA 01/2023 - 01/2019
4	abemaciclibIBA 08/2022 - 12/2020
4	Capecitabine (Xeloda)FDA Link 01/2021 - 01/2018
3	AntibodiesIBA 01/2024 - 06/2012
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2024 - 01/2022
3	LigandsIBA 06/2023 - 12/2018
3	sacituzumab govitecanIBA 05/2023 - 01/2022
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 01/2022
3	taxaneIBA 01/2023 - 01/2018
3	Tamoxifen FDA LinkGeneric 08/2022 - 10/2013
3	Bevacizumab (Avastin)FDA Link 01/2022 - 12/2013
3	pertuzumabIBA 01/2020 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 01/2018 - 02/2012
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2012
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2022 - 10/2021
2	palbociclibIBA 01/2022 - 04/2016
2	Circulating Tumor DNAIBA 01/2022 - 12/2018
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 12/2013
2	AZD9496IBA 01/2022 - 12/2018
2	AlpelisibIBA 01/2021 - 01/2020
2	Cyclin-Dependent Kinase 4IBA 01/2021 - 01/2020
2	atezolizumabIBA 01/2019 - 01/2019
2	B7-H1 AntigenIBA 01/2019 - 01/2019
2	130-nm albumin-bound paclitaxelIBA 01/2019 - 12/2013
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 04/2016 - 01/2011
2	VaccinesIBA 06/2012 - 02/2012
2	Tyrosine (L-Tyrosine)FDA Link 06/2012 - 09/2011
1	DHES0815AIBA 01/2024
1	TabletsIBA 01/2024
1	margetuximabIBA 11/2023
1	snake venom protein C activatorIBA 07/2023
1	Estrogens (Estrogen)FDA Link 07/2023
1	Cytotoxins (Cytolysins)IBA 05/2023
1	mirvetuximab soravtansineIBA 05/2023
1	AntigensIBA 05/2023
1	tisotumab vedotinIBA 05/2023
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2023
1	zanidatamabIBA 12/2022
1	Surface Antigens (Surface Antigen)IBA 12/2022
1	CalciumIBA 12/2022
1	Glycoproteins (Glycoprotein)IBA 12/2022
1	FCN-437cIBA 10/2022
1	rucaparibIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	RAD140IBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	dostarlimabIBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	BilirubinIBA 01/2022
1	ribociclibIBA 01/2021
1	NVP-BKM120IBA 01/2021
1	AntidiarrhealsIBA 01/2021

Therapy/Procedure

32	Therapeutics 01/2024 - 09/2011
9	Drug Therapy (Chemotherapy) 07/2023 - 12/2013
2	Aftercare (After-Treatment) 01/2022 - 01/2018
1	Immunotherapy 05/2023
1	Traction 05/2023
1	Precision Medicine 01/2022
1	Adjuvant Chemotherapy 01/2022
1	Drug Tapering 01/2021